News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Russia First To Approve Merck KGaA (MKGAF.PK) Multiple Sclerosis Pill Cladribine



7/12/2010 7:17:19 AM

FRANKFURT, July 12 (Reuters) - Russia is the first country to approve Merck KGaA's (MRCG.DE) new multiple sclerosis pill cladribine, giving the German drugmaker an edge in the emerging market against larger rival Novartis AG (NOVN.VX).

Read at Reuters


comments powered by Disqus
Reuters
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES